A systematic review and meta-analysis on gene-environment interaction effects on the associations of vitamin D and sun exposure with multiple sclerosis risk
Multiple Sclerosis and Related Disorders, https://doi.org/10.1016/j.msard.2025.106634
Mehari Woldemariam Merid a,b,* , Liyang Xu c, Yuan Zhou d, Ingrid van der Mei d,
Daniel J. Park e,f, Steve Simpson-Yap a,c,d Australia
Background: Multiple sclerosis (MS) is a complex neurological disease influenced by genetic and environmental factors, including low vitamin D and sun exposure. However, whether these interact with genetic loci is unclear. This systematic review and meta-analysis evaluated gene-environment interaction (GxE) studies on vitamin D and sun exposure in MS risk.
Methods: We searched relevant databases including Medline, Embase, CINAHL, and Web of Science from
conception until 8 June 2024. We included observational studies assessing GxE related to vitamin D and/or sun
exposure with MS risk. Environmental and genetic exposure and other relevant data were extracted and additive
interaction statistics including four-level interactions, synergy index (SI), relative excess risk due to interaction
(RERI), and attributable proportion due to interaction (AP) were meta-analysed for comparable studies. All
included studies were assessed for quality and risk of bias using recommended checklists.
Results: We included 11 studies (10,857 cases;11,842 controls), of which three examined gene-vitamin D, four gene-sun, and four both gene-vitamin D and gene-sun interactions. Studies used varied measures to assess vitamin D status, most commonly serum 25(OH)D levels, while sun exposure was primarily based on selfreported data. HLA-DRB1×15:01 variant was the most common genotype evaluated. Consistently, the joint effects of either low vitamin D or low sun exposure with the HLA-DRB1×15:01 risk variant were stronger than any individual factor.
Under stringent inclusion criteria, our meta-analysis focused on assessing additive interactions between low sun exposure and HLA-DRB1×15:01 with MS risk. We observed that carriers of both risk factors had a five-fold higher MS risk than those exhibiting neither factor (aOR=5.17;(95 %CI=4.39–6.17), SI=1.49, RERI=1.42, AP=0.28). No publication bias: heterogeneity was moderate.
Conclusions: Nearly half of MS risk was super-additive for low sun and HLA-DRB1×15:01 interactions and GxE was also evident for low vitamin D and MS risk genes, underscoring the importance of gene-environment interplay in MS risk prediction.
Download the PDF from VitaminDWiki
Related items in VitaminDWiki
Vitamin D
- Multiple Sclerosis risk is increased 50% if low Vitamin D - 19 study meta-analysis July 2025
- Multiple Sclerosis non-drug treatment – Vitamin D is the most popular (Austria – 42% of MSers in the study) – March 2025
- Vitamin D fights Multiple Sclerosis, Autoimmune, etc. - Dr. Coimbra video and transcript March 2025
- Multiple Sclerosis is treated by Vitamin D – 10 reasons – Sept 2024
- How Vitamin D fights Alzheimer’s, Parkinson’s, Multiple Sclerosis and Epilepsy – June 2023
- Multiple Sclerosis risk factors - Vitamin D was the only one you can easily change - Sept 2023
- COVID death rate was 3X lower in those with Multiple Sclerosis (85 pcnt were taking Vitamin D) - Jan 2022
Sun/UVB
- Multiple Sclerosis treated equally by UVB and weekly 50,000 IU of Vitamin D – RCT July 2023
- Vitamin D and sunshine are two ways to reduce MS relapses - May 2010
- Mutiple Sclerosis half as likely in children spending 30 to 60 minutes per day in the sun – Dec 2021
Other MS